Skip to Content

Health

CDC alerts doctors to watch for rare, serious bacterial infection appearing with unusual symptoms

By Brenda Goodman, CNN (CNN) — Health officials are alerting doctors to be on the lookout for certain types of rare, serious meningococcal infections that are on the rise in the United States. The US Centers for Disease Control and Prevention said in a new health alert that these infections, which are caused by a certain strain of Neisseria

Continue Reading

Supreme Court medication abortion case threatens ‘seismic shift’ in FDA drug approval process, experts warn

By Meg Tirrell and Tierney Sneed, CNN (CNN) — In 1937, a drugmaker called S.E. Massengill Co. came up with what seemed like an improvement on an effective medicine for sore throats: a liquid formulation that tasted like raspberry. The only problem: The new formulation of the drug, called sulfanilamide, used diethylene glycol, which is

Continue Reading

What is mifepristone?

By Jen Christensen, CNN (CNN) — The abortion pill mifepristone is the subject of ongoing lawsuits, as anti-abortion advocates have claimed that the drug is not safe and that the US Food and Drug Administration didn’t study it enough to approve it. Mifepristone was approved by the FDA decades ago and has been shown to

Continue Reading

With US Supreme Court abortion drug hearing looming, study shows how self-managed abortion became more common post-Dobbs

Medication abortion has become increasingly common since it first became available in the United States two decades ago, and a new study finds that requests for abortion pills through sources outside of the formal health-care system surged after the US Supreme Court’s Dobbs decision removed the federal right to an abortion.

Continue Reading

People with darker skin are 32% more likely to have pulse oximeter readings overestimate oxygen levels, report says

By Jacqueline Howard, CNN (CNN) — Scientists have long known that pulse oximeters are less accurate when used for people with dark skin tones – and now, a new report offers some insight into just how much more inaccurate these fingertip clamps can be. Pulse oximeters are electronic devices that clamp onto a patient’s finger

Continue Reading

Blueberries, strawberries again on the ‘Dirty Dozen’ list

By Sandee LaMotte, CNN (CNN) — Approximately 95% of nonorganic strawberries, leafy greens such as spinach and kale, collard and mustard greens, grapes, peaches and pears tested by the United States government contained detectable levels of pesticides, according to the 2024 Shopper’s Guide to Pesticides in Produce. Nectarines, apples, bell and hot peppers, cherries, blueberries

Continue Reading

A lifesaving therapy for children with a rare disease is now the world’s most expensive drug, raising questions about access

By Brenda Goodman, CNN (CNN) — A new gene therapy for the fatal genetic disorder metachromatic leukodystrophy, or MLD, will carry a wholesale price of $4.25 million, its manufacturer announced Wednesday, making it the world’s most expensive medicine. Lenmeldy was approved by the US Food and Drug Administration on Monday and is the first therapy for

Continue Reading

What to know about puberty blockers

By Kristen Rogers, CNN (CNN) — As England’s National Health Service has decided to stop prescribing puberty blockers to minors with gender dysphoria or gender incongruence, many people are asking what those are and why they’re such a hot-button issue. “Puberty blockers are sort of like a man-made hormone analogue, and basically what they do

Continue Reading

Toxic plastic chemicals number in the thousands, most are unregulated, report finds

“Life in plastic; it’s fantastic,” so the song goes, but in reality, plastics and the chemicals used to create them have been increasingly linked to numerous harms to human health and the environment. And with new plastic chemicals entering the market all the time, it’s been difficult for regulators and policy makers to determine the scope of the problem.

Continue Reading

A new $16,000 postpartum depression drug is here. How will insurers handle it?

By April Dembosky, KQED and KFF Health News (KQED/KFF Health News) — A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health insurers have yet to publish criteria for when they will cover it, according to a new analysis of insurance

Continue Reading